Clinical Trials
3 trialsNCT07102394 2026-05-08
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Johns Hopkins University
Phase 1 Recruiting
NCT03886311 2025-02-24
TNT
Sarcoma Oncology Research Center, LLC
Phase 2 Recruiting
NCT03842943 2024-05-02
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
University of Louisville
Phase 2 Recruiting